<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01546610</url>
  </required_header>
  <id_info>
    <org_study_id>1348/09</org_study_id>
    <nct_id>NCT01546610</nct_id>
  </id_info>
  <brief_title>Rheumatoid Foot Insole</brief_title>
  <official_title>Effect of Rheumatoid Foot Insole</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study aims to evaluate the effect of insoles for foot arthritis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized, controlled, double-blind, prospective trial being conducted involving 80
      patients with rheumatoid arthritis, according to American College of Rheumatology (ACR)
      criteria, and foot pain, selected from outpatient clinics - Federal University of Sao Paulo
      (UNIFESP).

      Patients will be randomized in to two groups: experimental (40) and control (40).

      The experimental group will use ethyl-vinyl acetate (EVA) foot orthoses, with support
      retrocapital and support of medial arch (insole intervention). The control group will use the
      same material flat insole (insole placebo).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">November 2012</completion_date>
  <primary_completion_date type="Anticipated">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analog scale of pain in feet during walking (VAS)</measure>
    <time_frame>12 months</time_frame>
    <description>Assessing pain in the feet during walking through a visual analog scale from 0 to 10 centimeter (cm)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Foot Function Index (FFI)</measure>
    <time_frame>12 months</time_frame>
    <description>Function of the foot</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Foot Health Status Questionnaire (FHSQ-Br)</measure>
    <time_frame>12 months</time_frame>
    <description>Foot Health Status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Assessmente Questionnaire (HAQ)</measure>
    <time_frame>12 months</time_frame>
    <description>Functional capacity assessed by HAQ in rheumatoid arthritis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog scale of pain in feet at rest (VAS)</measure>
    <time_frame>12 months</time_frame>
    <description>Assessing pain in the feet at rest through a visual analog scale from 0 to 10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6-MINUTE WALK TEST</measure>
    <time_frame>12 months</time_frame>
    <description>Assess functional capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shorth Form-36 (SF-36)</measure>
    <time_frame>12 months</time_frame>
    <description>Quality of life by SF-36</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LIKERT SCALE</measure>
    <time_frame>12 months</time_frame>
    <description>Likert scale by patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TESTS BAROPODOMETRIC</measure>
    <time_frame>12 months</time_frame>
    <description>Evaluates charge distribution in the feet and gait variables</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TIME USE OF INSOLE</measure>
    <time_frame>12 months</time_frame>
    <description>Control the use of time insole</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>intervention foot orthoses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ethyl vinyl acetate (EVA) insole with medial arch support and bar retrocapital</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo insole</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Foot orthose with support retrocapital and support of medial arch insole intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>insoles intervention</intervention_name>
    <description>EVA insole with arch support and bar retrocapital</description>
    <arm_group_label>intervention foot orthoses</arm_group_label>
    <other_name>Interventional group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo insole</intervention_name>
    <description>EVA insole flat</description>
    <arm_group_label>placebo insole</arm_group_label>
    <other_name>control group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with established diagnosis RA according to criteria of the American College
             of Rheumatology (ACR) functional classes I, II and III

          -  Foot pain with VAS between 3 - 8 cm for walking

          -  Age 18-65 years

          -  Basic medication stable for at least three months

          -  Not made infiltrations in feet and ankles in the last three months and not during the
             study

          -  Agreed to participate and signed term of informed consent

        Exclusion Criteria:

          -  Other musculoskeletal disorders in symptomatic lower limbs

          -  Diseases of the central and peripheral nervous system

          -  Decompensated diabetes mellitus

          -  No walking

          -  Rigid deformities in the feet

          -  Use of insoles in the last three months

          -  Surgery scheduled in the next 12 months

          -  Allergy to the material

          -  Mental deficiency
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>EMILIA MOREIRA, PT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>ANAMARIA PT JONES, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Federal University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>JAMIL NATOUR, PHD</last_name>
    <role>Study Chair</role>
    <affiliation>Division of Rheumatology, Federal University of Sao Paulo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emilia Moreira</last_name>
    <phone>551125942014</phone>
    <email>emilia.moreira@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jamil MD Natour, PHD</last_name>
    <phone>551155764239</phone>
    <email>jnatour@unifesp.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Emilia Moreira</name>
      <address>
        <city>Sao Paulo</city>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emilia PT Moreira</last_name>
      <phone>551125942014</phone>
      <email>emilia.moreira@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jamil MD Natour, PHD</last_name>
      <phone>551155764239</phone>
      <email>jnatour@unifesp.br</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2012</study_first_submitted>
  <study_first_submitted_qc>March 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2012</study_first_posted>
  <last_update_submitted>March 8, 2012</last_update_submitted>
  <last_update_submitted_qc>March 8, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 9, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>Emilia Moreira, PT</investigator_full_name>
    <investigator_title>Effect of rheumatoid foot insole</investigator_title>
  </responsible_party>
  <keyword>Rheumatoid foot</keyword>
  <keyword>foot pain</keyword>
  <keyword>insoles</keyword>
  <keyword>foot function</keyword>
  <keyword>electronic baropodometer</keyword>
  <keyword>plantar pressure</keyword>
  <keyword>gait analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

